SEC Form 4 · accession 0001645627-18-000003
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 8, 2018
Accepted (ET)
Jan 12, 2018 · 3:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 8, 2018 | P | 3,000 | $0.058 | A | 24,701,189 | D | |
| Common Stock | Jan 9, 2018 | P | 3,000 | $0.054 | A | 24,704,189 | D | |
| Common Stock | Jan 9, 2018 | P | 3,000 | $0.053 | A | 24,707,189 | D | |
| Common Stock | Jan 9, 2018 | P | 3,000 | $0.053 | A | 24,710,189 | D | |
| Common Stock | Jan 10, 2018 | P | 1,000 | $0.0549 | A | 24,711,189 | D | |
| Common Stock | Jan 10, 2018 | P | 2,000 | $0.0547 | A | 24,713,189 | D | |
| Common Stock | Jan 10, 2018 | P | 2,000 | $0.0538 | A | 24,715,189 | D | |
| Common Stock | Jan 10, 2018 | P | 2,000 | $0.0528 | A | 24,717,189 | D |
Table II — derivative securities
No Table II lines on this filing.